Terapi Oksigen Hiperbarik yang Berkaitan dengan Paru
DOI:
https://doi.org/10.29303/jk.v15i2.9219Keywords:
HBOT, DCS, AGE, Keracunan Karbon MonoksidaAbstract
Terapi Oksigen Hiperbarik (HBOT) merupakan modalitas terapeutik yang melibatkan pemberian oksigen murni (100%) pada tekanan atmosfer tinggi (biasanya ≥2 ATA). Terapi ini memiliki landasan fisiologis dalam meningkatkan tekanan parsial oksigen dalam plasma, sehingga mengatasi hipoksia jaringan dan mempercepat resolusi gelembung gas. Artikel ini mengkaji perkembangan historis, mekanisme fisiologis, indikasi utama yang berkaitan dengan paru, sistem pemberian, jadwal perawatan, serta efek samping dan kontraindikasi HBOT. Penggunaan HBOT secara medis terutama ditunjukkan untuk kondisi akut yang melibatkan hipoksia atau pembentukan gelembung gas. Tiga indikasi utama yang dibahas adalah: (1) Keracunan Karbon Monoksida (CO), di mana HBOT mempercepat eliminasi CO dari hemoglobin dan mengurangi morbiditas neurologis; (2) Arterial Gas Embolism (AGE) dan Decompression Sickness (DCS), di mana HBOT mengurangi volume gelembung gas dan memperbaiki gejala melalui mekanisme rekompresi dan hiperoksigenasi; serta (3) Emfisema Subkutis, di mana HBOT membantu absorpsi gas dari jaringan lunak. Meskipun efektif, HBOT memiliki potensi efek samping seperti barotrauma (terutama pada telinga dan sinus) serta kontraindikasi, termasuk pneumotoraks yang tidak ditangani dan kondisi pernapasan tertentu. Kesimpulannya, HBOT merupakan terapi yang sangat bermanfaat untuk kondisi-kondisi spesifik dengan dasar patofisiologi hipoksia atau gelembung gas, namun memerlukan pertimbangan yang cermat terhadap protokol, keamanan, dan kelayakan pasien.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Mc Syaiful Ghazi Yamani, Suryani Padua Fatrullah
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Unram Medical Journal, agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, websites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in University of Mataram's Journal of Medicine.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- This journal is open access journal which means that all content is freely available without charge to users or / institution. Users are allowed to read, download, copy, distribute, print, search, or link to full text articles in this journal without asking prior permission from the publisher or author.
